Even if 20 enrolled participants have completed, full data will already be completed for those people and will be accessible to OBJ and P&G.
This is the reason why "mass production" snippets of Info have already been released.
It's not a question of will it work (this is not the first study of this nature that has been done).
This is simply the "large, 114 patients test" so the numbers can be used for advertising purposes and to "double tick" the "it works" box for P&G, further verified by independent sources with a larger pool of people.
A release could quite possibly come prior to the full "114" participants being recruited and read along the lines of "initial results from double blind Bodyguard testing exceeds expectations".
On the other hand, they may simply update us with respect to the Manufacturing process and we have to wait until end of anticipated trial close mid-December for results-based news.
Either way, within 6months Bodyguard will be tangible and the market fully aware of the outcome.
If bodyguard is secured by P&G as their worldwide exclusive signals is more than likely, BG will be a company making product - stand alone.
Completely Irrespective of every other iron in the proverbial fire.
1-5% commission? No.
This is a different kettle of fish than the wand applicator. This is a home grown product, developed and honed by OBJ. The ball is in our court.
This is where Steve Meller will earn his keep.
All in my opinion only.
Kiwi.
OBJ Price at posting:
6.2¢ Sentiment: Buy Disclosure: Held
(20min delay)